Palisade Bio
PALI
10 hedge funds and large institutions have $229K invested in Palisade Bio in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
668% more capital invested
Capital invested by funds: $29.8K → $229K (+$199K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 → 10 (+2)
0.12% more ownership
Funds ownership: 0.01% → 0.13% (+0.12%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$49.9K |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.4K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$2.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.05K |
| 3 |
JP Morgan Chase
New York
|
-$2K |
| 4 |
Morgan Stanley
New York
|
-$1.97K |
| 5 |
OCM
Orion Capital Management
Coronado,
California
|
-$1.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $71.8K | +$70.3K | +2,816 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $60.5K | +$59.2K | +2,371 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| $51K | +$49.9K | +2,000 | New |
|
|
4
State Street
Boston,
Massachusetts
| $38.2K | +$37.4K | +1,498 | New |
|
|
5
Morgan Stanley
New York
| $3.47K | -$1.97K | -79 | -37% |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.58K | +$2.52K | +101 | New |
|
7
Wells Fargo
San Francisco,
California
| $633 | +$75 | +3 | +14% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $376 | +$175 | +7 | +88% |
|
|
9
UBS Group
Zurich,
Switzerland
| $184 | -$2.05K | -82 | -92% |
|
10
BlackRock
New York
| $15 | – | – | – |
|
11
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $2 | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$9K | -165 | Closed |
|
|
13
JP Morgan Chase
New York
| – | -$2K | -42 | Closed |
|
|
OCM
14
Orion Capital Management
Coronado,
California
| – | -$1.05K | -20 | Closed |
|
PALI Hedge Fund Activity: Q2 2023 in Review
10 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2023, worth a combined $229K — up 668% from $29.8K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PALI positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $70.3K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $9K sold.
- 10 institutional investors held Palisade Bio (PALI) as of Q2 2023, up from 8 in Q1 2023.
- Funds reported $229K of Palisade Bio stock for Q2 2023, up 668% quarter-over-quarter.
- 5 funds opened new Palisade Bio positions in Q2 2023 and 3 closed out, a net change of +2 holders.
- The largest Palisade Bio buyer in Q2 2023 was Geode Capital Management, an estimated $70.3K added.
- The largest Palisade Bio seller in Q2 2023 was Tower Research Capital (TRC), an estimated $9K sold.
Based on aggregated 13F filings for Q2 2023.